Sudarshan Chemical Industries Ltd

- There is no explicit mention of any current or planned fundraising through debt or equity in the transcript provided. - The company has focused on reducing net debt significantly, from INR 926 crores in Q2 FY'23 to INR 445 crores in Q2 FY'24, indicating a deleveraging approach rather than new borrowing. - Management discussed internal capex and capacity ramp-up funded through existing resources, without reference to external fundraising. - The Board is reviewing the status of RIECO Industries for possible divestment, which might be a source of funds, but no concrete fundraising plan is disclosed. - Overall, no announcements or plans for fresh debt or equity fundraising were communicated in this call.

- Sudarshan Chemical Industries recently commissioned new capex with expanded product offerings, currently at lower utilization but on target for ramp-up (Page 11). - The ramp-up and revenue scale-up from new capex are expected over a conservative 4-year period (Page 14). - The new capex is largely focused on specialty pigments to increase specialty revenue share (Page 13). - No mention of any new product development capex; the company states product development projects are complete (Page 8). - The company is pursuing cost improvement and value chain integration projects (Page 7). - Board is reviewing the strategic decision on divesting subsidiary RIECO Industries but no final decision yet (Page 9). - Investment in European distribution set-up expanded with a pan-European distributor to enhance market reach (Pages 9 & 15).

- The company expects top-line growth to reach INR 3,000 to 3,300 crores over the next 3 to 4 years, with guidance revised to a slightly longer 4-year period considering current global conditions. - Revenue growth is expected to be largely volume-driven, with softening raw material prices aiding margins. - New capex and expanded product portfolio are on track, with meaningful ramp-up expected over the next 1-4 years. - Growth is anticipated primarily from coatings, plastics, and cosmetics applications, with coatings expected to see larger growth. - Export markets, including the U.S. and Europe, are targeted for increased penetration, including through improved distribution models. - Volume growth has been strong despite overall market softness, aided by market share gains in new geographies and product launches. - EBITDA margins are expected to improve beyond pre-COVID levels due to the specialty product mix and higher capacity utilization.

- Sudarshan Chemical Industries is on track to scale up revenue from recently commissioned capex over a conservative 4-year period, extending earlier 3-year guidance. - The company expects EBITDA margins to improve structurally over 3-5 years, potentially exceeding pre-COVID levels of 15%, driven by an expanded specialty product portfolio. - Current EBITDA margin improvements (12.8% in Q2 FY24 vs. 8.2% last year) are supported by volume growth, improved product mix, and softer raw material costs. - Revenue growth is volume-driven despite a softening price regime; new product sales are ramping up progressively and expected to contribute significantly in coming years. - Export volumes have grown steadily (5% increase in H1 FY24 YoY) despite global destocking and market pressures. - The company anticipates long-term margin momentum due to higher utilization and new product scaling, targeting margins above previous peaks. - Profit after tax showed improvement from INR5 crores to INR18 crores YoY in Q2 FY24, indicating positive future earnings trajectory.

- RIECO Industries, a subsidiary of Sudarshan Chemical Industries, has seen a significant increase in order book and revenues. - Current year revenue for RIECO stands at INR 151 crores compared to INR 80 crores last year, indicating a strong upcycle in the capital goods industry. - The company expects RIECO to continue this positive trend and improve further from INR 233 crores of revenue in the previous year. - No specific details on total current or expected order book across the entire Sudarshan Chemical Industries business are provided. - Management highlights ongoing good traction from the recently commissioned capex and product portfolio, with a ramp-up expected over a 4-year period. - Engagement with European distribution tie-ups is active, aiming to expand mid-size and smaller customer approvals and grow sales in the medium term.